Asia-Pacific Animal Healthcare Market Outlook, 2030

The Asia-Pacific animal healthcare market is witnessing significant growth, fueled by increasing demand for livestock disease management and the rising trend of pet ownership across developing economies. Countries such as China, India, Japan, Australia, and South Korea are emerging as key contributors due to rapid urbanization, higher disposable incomes, and growing awareness of animal health and welfare. The livestock sector remains dominant, with farmers investing more in vaccinations, parasite control, and nutrition to ensure productivity and prevent outbreaks of diseases like foot-and-mouth disease, avian influenza, and swine fever.

Additionally, the market is experiencing heightened investments in R&D, portfolio acquisition, etc., fostering market growth in the country. For example, in October 2024, the Government of India (GoI), in partnership with the Asian Development Bank and FAO, announced USD 25 million in funding to enhance “animal health security” with the help of multiple initiatives to develop holistic health coverage. Regulatory frameworks across Asia-Pacific are evolving to support safe and efficient veterinary practices, with nations like Japan and Australia implementing stringent quality standards, though challenges remain with varying regulations across countries that can delay product approvals.

Government-led initiatives, such as India's National Animal Disease Control Programme, are playing a pivotal role by funding mass vaccination campaigns and boosting veterinary infrastructure. However, the market still faces hurdles such as a shortage of trained veterinary professionals, inconsistent access to advanced medical tools in remote regions, and high costs of treatments and diagnostics.

According to the research report "Asia Pacific Animal Healthcare Market Outlook, 2030," the Asia Pacific Animal Healthcare market is anticipated to grow at more than 9.67% CAGR from 2025 to 2030. With increasing demand for meat, dairy, and poultry products, there is a heightened focus on improving animal productivity and reducing disease-related losses. This has led to greater investment in veterinary vaccines, feed additives, and diagnostic tools to ensure the health and efficiency of farm animals.

Governments in the region are actively supporting these efforts; for instance, India’s National Animal Disease Control Programme (NADCP) aims to vaccinate over 500 million livestock against foot-and-mouth disease and brucellosis, significantly contributing to the market’s growth. Meanwhile, urbanization and rising disposable incomes are fostering a parallel trend in the companion animal sector. Countries such as Japan, South Korea, China, and Australia are experiencing a sharp rise in pet ownership, with pets increasingly considered family members. This cultural shift has accelerated demand for premium pet care, including routine veterinary checkups, grooming, and advanced treatments such as orthopedic surgeries and oncology care.

The integration of artificial intelligence, wearable monitoring devices, and tele-veterinary platforms is revolutionizing both livestock management and pet healthcare. For example, AI-based diagnostic imaging tools and automated monitoring systems are enabling early disease detection and improved treatment outcomes. Companies in countries like Japan and South Korea are at the forefront of such developments, launching smart clinics and AI-powered platforms for real-time veterinary decision-making. Furthermore, in September 2024, the 25th International Conference on Veterinary Medicine at Khon Kaen University in Thailand emphasized the transformative role of AI and technology in veterinary science.

Key discussions included advancements in imaging techniques, regenerative medicine, and minimally invasive surgical procedures, showcasing how these innovations enhance animal health and welfare. SK Telecom, a South Korean company, expanded its AI-based veterinary care service, X Caliber, to Southeast Asia, partnering with local companies to enhance veterinary diagnostics in Malaysia, Thailand, and Vietnam.

Market Drivers

• Rising Livestock Production and Demand for Animal Protein: One of the strongest drivers in the Asia-Pacific region is the growing demand for meat, dairy, and poultry products due to population growth, urbanization, and rising incomes. Countries such as China, India, Vietnam, and Indonesia are increasing livestock production to meet dietary changes and food security goals. This surge in livestock farming necessitates comprehensive animal healthcare solutions, including vaccines, antibiotics, nutritional supplements, and disease management programs. Governments and private players are also investing in biosecurity measures and veterinary infrastructure to prevent disease outbreaks, further driving market growth.
• Increase in Pet Ownership and Urban Middle-Class Spending: The rapid rise in pet ownership, especially in urban centers across China, India, South Korea, and Southeast Asia, is another major market driver. This trend is driven by a growing middle class, changing lifestyle preferences, and increased emotional connection with pets. As more households consider pets as family members, spending on pet health, grooming, vaccinations, and preventive care has risen sharply. Veterinary clinics and pet wellness centers are expanding in metropolitan areas, creating robust demand for companion animal pharmaceuticals and services in the region.

Market Challenges

• Limited Veterinary Infrastructure in Rural Areas: Despite regional growth, a significant challenge in the Asia-Pacific animal healthcare market is the lack of veterinary infrastructure in rural and remote areas. Many parts of India, Southeast Asia, and China still suffer from limited access to professional veterinary services, diagnostic labs, and quality animal healthcare products. Livestock farmers in these regions often rely on untrained practitioners or traditional remedies, which can lead to underdiagnosed or mistreated animal diseases. This infrastructure gap limits market penetration and contributes to ongoing health and productivity issues in the animal farming sector.
• Regulatory Diversity and Product Approval Delays: The fragmented regulatory environment across the Asia-Pacific region poses another major hurdle. Each country has its own laws and approval processes for veterinary medicines, biologics, and feed additives. These differences make it challenging for manufacturers to navigate compliance, leading to delays in product launches and added costs. Inconsistent enforcement and a lack of harmonized standards also hinder foreign investment and technology transfer. For multinational companies, navigating complex and varied regulatory pathways remains a critical barrier to market expansion in the region.

Market Trends

• Adoption of Preventive Healthcare and Digital Veterinary Solutions: A growing trend in Asia-Pacific is the shift from reactive treatment to preventive animal healthcare. More pet owners and livestock producers are now investing in regular vaccinations, deworming, and nutritional supplements to prevent disease rather than cure it. At the same time, the region is seeing a rise in digital veterinary solutions such as telemedicine, mobile vet consultations, and AI-driven diagnostics. Countries like Japan and South Korea are leading in digital vet tech adoption, while smartphone penetration is enabling broader access to remote healthcare services in rural and semi-urban areas.
• Focus on Sustainable Livestock Practices and Reduced Antibiotic Use: Sustainability is becoming an important trend in Asia-Pacific’s livestock industry. With rising concerns over antibiotic resistance, there is a clear shift toward more sustainable farming practices, including the use of vaccines, probiotics, and natural alternatives to antibiotics. Governments and industry bodies are introducing stricter regulations and guidelines to reduce antibiotic overuse in animal agriculture. In countries like China and Vietnam, policies are being enforced to phase out growth-promoting antibiotics, which is pushing producers to adopt healthier and more sustainable herd management practices.

The growing demand for animal protein and increasing livestock production in emerging economies like China, India, and Southeast Asia are driving the growth of the livestock animals segment in the Asia Pacific animal healthcare industry.

The livestock animals or production animals segment is experiencing significant growth in the Asia Pacific animal healthcare industry, primarily due to the surging demand for meat, dairy, and other animal-derived products driven by rising population, urbanization, and changing dietary preferences across the region. Countries like China, India, Indonesia, Vietnam, and Thailand are witnessing increased consumption of beef, pork, poultry, and dairy, prompting farmers and agribusinesses to expand livestock farming operations.

This expansion requires improved animal health management practices to ensure productivity, disease control, and food safety, thereby boosting the demand for veterinary pharmaceuticals, vaccines, diagnostics, and nutritional supplements tailored to production animals. The economic shift in many Asia Pacific nations has led to growing middle-class populations with higher disposable incomes, which directly correlates to increased demand for high-protein diets and better-quality animal products. Additionally, government initiatives aimed at enhancing livestock productivity and safeguarding food security are supporting infrastructure development, veterinary services, and livestock immunization programs.

For instance, India’s National Animal Disease Control Programme (NADCP) and similar initiatives in China are focused on eradicating major animal diseases such as Foot-and-Mouth Disease (FMD) and Brucellosis, thereby propelling market growth for livestock healthcare products. Moreover, the intensification of animal farming and the shift toward commercial production systems require advanced disease prevention and health monitoring solutions to manage large herds effectively, thus creating a fertile ground for animal healthcare providers.

The dominance of pharmaceuticals in the Asia Pacific animal healthcare industry is primarily driven by the high prevalence of infectious diseases in livestock and companion animals, necessitating widespread use of therapeutic treatments and preventive medications.

Pharmaceuticals hold a leading position in the Asia Pacific animal healthcare industry due to the critical need for effective disease management across both livestock and companion animals in a region marked by diverse climatic conditions, dense animal populations, and intensive farming practices. Infectious diseases such as Foot-and-Mouth Disease (FMD), avian influenza, swine fever, and parasitic infections are widespread in many parts of Asia, posing significant threats to animal productivity, public health, and food security.

This has created a strong and consistent demand for pharmaceutical products such as antibiotics, antiparasitics, anti-inflammatories, and hormonal therapies that are essential for treating illnesses and ensuring optimal animal health. Rapid urbanization and population growth across major economies like China, India, Indonesia, and Vietnam have led to increased consumption of animal protein, putting pressure on producers to maintain healthy and productive livestock populations through the strategic use of pharmaceuticals. Additionally, the rise in pet ownership and the growing emotional and financial investment in companion animals have further fueled demand for veterinary drugs used in treating chronic and acute conditions in pets.

Governments across the region are actively supporting animal disease control programs, vaccination drives, and livestock immunization schemes, all of which are heavily reliant on pharmaceutical inputs. For instance, India’s extensive FMD vaccination campaign and China’s swine fever control initiatives have significantly boosted the use of veterinary drugs. The growing awareness among farmers and pet owners about the benefits of timely medication, along with improved access to veterinary services and pharmaceuticals, particularly in rural and semi-urban areas, has also contributed to this trend.

The oral delivery mode is leading in the Asia Pacific animal healthcare industry due to its ease of administration, cost-effectiveness, and suitability for mass medication in large-scale livestock farming operations.

Oral delivery mode dominates the Asia Pacific animal healthcare industry primarily because it offers a practical, efficient, and economically viable solution for administering medications, especially in large-scale and intensive livestock farming systems prevalent across the region. In countries like China, India, Indonesia, and Vietnam, where livestock production is expanding rapidly to meet the growing demand for animal protein, farmers and producers are increasingly relying on oral medications such as medicated feed additives, water-soluble drugs, and boluses to ensure disease control and promote animal growth.

This method allows for the simultaneous treatment of large groups of animals without the need for individual handling, significantly reducing labor costs and stress on animals. The convenience of incorporating drugs directly into feed or water makes it particularly ideal for poultry, swine, and aquaculture sectors, which are highly prominent in Asia Pacific. Moreover, the oral route eliminates the risks associated with invasive delivery methods like injections, such as injury, infection, and the need for skilled personnel, making it highly suitable for use in rural or resource-limited settings where veterinary infrastructure may be underdeveloped.

The cost-effectiveness of oral delivery not only reduces treatment expenses for farmers but also supports preventive healthcare practices by allowing regular supplementation of vitamins, minerals, and probiotics that help maintain animal health and productivity. As awareness of biosecurity and food safety increases across the region, there is growing emphasis on administering routine medications and preventive treatments through easily manageable oral formulations.

Retail pharmacies are experiencing moderate growth in the Asia Pacific animal healthcare industry due to the expanding urban pet population combined with increasing access to veterinary pharmaceuticals through conventional retail channels.

The moderate growth of retail pharmacies in the Asia Pacific animal healthcare industry is primarily driven by the growing number of companion animals in urban and semi-urban households, particularly in emerging economies such as India, China, Thailand, and Indonesia. As pet ownership becomes more prevalent among the middle class in these regions, there is an increasing demand for accessible and affordable animal healthcare products, including antiparasitics, antibiotics, vaccines, nutritional supplements, and grooming items. Retail pharmacies, especially those located in urban and peri-urban areas, are strategically positioned to meet this demand due to their local presence, convenience, and trust among consumers.

These pharmacies often serve as the first point of contact for pet owners seeking over-the-counter medications or basic health consultations, especially where veterinary clinics may be limited or expensive. Additionally, governments across several Asia Pacific countries are gradually enhancing the regulation of veterinary drugs and improving the supply chain, which is helping to ensure the availability of quality and approved animal healthcare products at retail outlets. However, the growth remains moderate rather than rapid due to certain limitations.

One of the key factors slowing down the segment’s acceleration is the rise of e-commerce and online veterinary platforms, which are offering a wider product range, better discounts, and home delivery options that appeal to tech-savvy urban consumers. Moreover, retail pharmacies are often constrained by limited shelf space, lack of specialized veterinary knowledge among staff, and insufficient cold chain facilities for storing temperature-sensitive vaccines and biologics.

Veterinary reference laboratories are leading in the Asia Pacific animal healthcare industry due to the increasing demand for advanced diagnostic services to manage disease outbreaks, ensure food safety.

The veterinary reference laboratories segment is taking the lead in the Asia Pacific animal healthcare industry as the region faces growing pressure to improve disease surveillance, enhance animal health management, and comply with international food safety and trade regulations. With the rapid expansion of livestock and poultry farming in countries like China, India, Indonesia, and Vietnam to meet the escalating demand for meat, milk, and eggs, there is a heightened need for precise, timely, and large-scale diagnostic services that can monitor animal health, detect diseases early, and guide treatment strategies.

Veterinary reference laboratories offer high-throughput, specialized testing capabilities that go beyond what is available in smaller clinics or on-farm setups, making them critical in the fight against endemic and emerging diseases such as avian influenza, swine fever, brucellosis, and foot-and-mouth disease. These laboratories play a central role in national animal disease control programs, supporting government surveillance systems with accurate data collection, pathogen identification, and epidemiological analysis.

As governments across the region invest in strengthening animal health infrastructure, reference laboratories are receiving significant support in the form of funding, modernization, and training. Additionally, the growing trend of intensive farming practices, which involve densely packed animal populations, increases the risk of rapid disease spread - necessitating routine laboratory testing and preventive screening facilitated by reference labs.

China is leading the Asia Pacific animal healthcare industry due to its massive livestock population, rapidly growing pet ownership, and heavy investments in veterinary infrastructure and biotechnology.

China’s leadership in the Asia Pacific animal healthcare industry is primarily driven by the scale of its livestock sector, the explosive growth of companion animal ownership, and its strategic investments in veterinary infrastructure, research, and biotechnology. As the world’s largest producer and consumer of pork and a major player in poultry and aquaculture, China has an enormous demand for animal health solutions to maintain productivity, prevent disease outbreaks, and ensure food safety.

The country’s past experience with large-scale epidemics like African Swine Fever (ASF) has underscored the critical importance of effective animal healthcare systems, leading to the implementation of stronger disease surveillance programs, biosecurity protocols, and government-supported vaccination campaigns. Simultaneously, urbanization and rising disposable incomes have led to a cultural shift, with a booming pet population especially dogs and cats further accelerating demand for veterinary services, diagnostics, and pet medicines.

The companion animal market in China is now one of the fastest-growing in the world, and pet owners are increasingly willing to invest in preventive healthcare, wellness services, and specialized treatments, including pet insurance and digital health solutions. Recognizing the economic and public health value of a strong animal healthcare system, the Chinese government has made substantial investments in biotechnology and veterinary research, promoting the development of domestic pharmaceutical manufacturing capabilities and encouraging partnerships with global firms. These efforts are further supported by national policies aimed at modernizing animal farming practices, reducing antibiotic misuse, and aligning with international health and safety standards.

Considered in this report

• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report

• Animal healthcare Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Animal type

• Companion Animals
• Livestock Animals / Production Animals

By Product type

• Pharmaceuticals
• Vaccines
• Feed Additives
• Diagnostics
• Other Products

By Delivery Mode

• Oral
• Parenteral
• Others

By Distribution Channel

• Veterinary Hospitals & Clinics
• Retail Pharmacies
• Online Pharmacies

The approach of the report:

This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analyzing the government generated reports and databases.

After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources.

Intended audience

This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to this industry, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.